IRIS
PASSALACQUA, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 60.564
AS - Asia 5.678
NA - Nord America 5.096
Continente sconosciuto - Info sul continente non disponibili 757
SA - Sud America 498
AF - Africa 100
OC - Oceania 10
Totale 72.703
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 59.489
US - Stati Uniti d'America 4.719
SG - Singapore 2.419
CN - Cina 1.371
VN - Vietnam 813
FR - Francia 502
BD - Bangladesh 467
BR - Brasile 297
HK - Hong Kong 199
FI - Finlandia 197
CA - Canada 129
DE - Germania 106
MX - Messico 75
AR - Argentina 74
JP - Giappone 73
GB - Regno Unito 61
IQ - Iraq 48
IN - India 40
JM - Giamaica 38
CO - Colombia 35
NL - Olanda 34
CH - Svizzera 33
ID - Indonesia 33
CR - Costa Rica 29
EC - Ecuador 29
PH - Filippine 27
TH - Thailandia 27
VE - Venezuela 23
ES - Italia 22
HN - Honduras 19
PK - Pakistan 19
TR - Turchia 19
RU - Federazione Russa 18
GT - Guatemala 17
JO - Giordania 17
ZA - Sudafrica 17
EG - Egitto 16
KR - Corea 15
IE - Irlanda 14
SV - El Salvador 14
SC - Seychelles 13
TT - Trinidad e Tobago 13
CL - Cile 12
MA - Marocco 12
NI - Nicaragua 12
UA - Ucraina 12
SA - Arabia Saudita 11
MY - Malesia 10
PE - Perù 10
PT - Portogallo 9
TW - Taiwan 9
AT - Austria 8
AU - Australia 8
AZ - Azerbaigian 8
DZ - Algeria 8
NP - Nepal 8
UY - Uruguay 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
KZ - Kazakistan 7
LT - Lituania 7
BE - Belgio 6
DO - Repubblica Dominicana 6
KE - Kenya 6
PL - Polonia 6
PR - Porto Rico 6
RO - Romania 6
BO - Bolivia 5
PY - Paraguay 5
BB - Barbados 4
GD - Grenada 4
SE - Svezia 4
AL - Albania 3
BG - Bulgaria 3
BS - Bahamas 3
CW - ???statistics.table.value.countryCode.CW??? 3
CY - Cipro 3
KG - Kirghizistan 3
MD - Moldavia 3
NE - Niger 3
OM - Oman 3
PA - Panama 3
SI - Slovenia 3
SN - Senegal 3
TN - Tunisia 3
AM - Armenia 2
AW - Aruba 2
BA - Bosnia-Erzegovina 2
BF - Burkina Faso 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
ET - Etiopia 2
HU - Ungheria 2
LB - Libano 2
LV - Lettonia 2
MM - Myanmar 2
NA - Namibia 2
NG - Nigeria 2
Totale 71.921
Salva come PNG Salva come JPEG
Città #
Genova 41.035
Genoa 10.373
Rapallo 4.496
Vado Ligure 2.986
San Jose 1.171
Singapore 1.136
Lauterbourg 481
Ashburn 445
New York 230
Ho Chi Minh City 218
Hanoi 193
Helsinki 191
Hong Kong 181
Santa Clara 152
Beijing 136
Los Angeles 96
Council Bluffs 87
Dallas 83
Frankfurt am Main 81
Bordighera 71
Milan 69
Tokyo 64
Chicago 59
Rome 54
Mexico City 46
Phoenix 46
Buffalo 37
Haiphong 37
Da Nang 36
Naples 35
Tianjin 35
Houston 33
Zurich 29
San Francisco 27
Atlanta 25
São Paulo 24
Philadelphia 23
San José 23
Kingston 22
Turin 22
Toronto 21
Las Vegas 20
Baghdad 19
Orem 19
Brooklyn 18
Amsterdam 17
Bangkok 17
Washington 17
City of London 16
Denver 16
Bologna 15
Dublin 15
Amman 14
Biên Hòa 14
Boston 14
Columbus 14
Nuremberg 14
Can Tho 13
Des Moines 13
San Salvador 13
Shanghai 13
The Bronx 13
Guatemala City 12
Guayaquil 12
London 12
Miami 12
Montreal 12
Newark 12
Seattle 12
Belo Horizonte 11
Cardiff 11
Guangzhou 11
Kansas City 11
Managua 11
Charlotte 10
Detroit 10
Indpls 10
Jakarta 10
Louisville 10
Richmond 10
San Antonio 10
Orlando 9
Rio de Janeiro 9
St Louis 9
Bari 8
Bogotá 8
Cleveland 8
Dhaka 8
Florence 8
Fort Wayne 8
Hải Dương 8
Jacksonville 8
Memphis 8
Montevideo 8
Nha Trang 8
Orangeburg 8
Palermo 8
Paris 8
Princeton 8
Quito 8
Totale 65.297
Salva come PNG Salva come JPEG
Nome #
IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper 403
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 352
Immunoterapia specifica: una possibilità di gestione del rischio professionale da allergia al veleno di imenotteri 253
Personalized medicine in allergy 217
Adhesion molecules in allergy. 215
A Review of the Evidence from Comparative Studies of Levocetirizine and Desloratadine for the Symptoms of Allergic Rhinitis 214
A critical evaluation of Anti-IL-13 and Anti-IL-4 strategies in severe asthma 213
Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. 210
Cetirizine reduces inflammatory cell recruitment and ICAM-1 (or CD54) expression on conjunctival epithelium in both early and late phase reactions after allergen-specific challenge. 208
Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision 208
A double-blind, placebo-controlled study on the diagnostic accuracy of an electrodermal test in allergic subjects. 205
A three-year double-blind placebo-controlled study with specific oral immunotherapy to Dermatophagoides: evidence of safety and efficacy in paediatric patients. 205
Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: An ARIA-EAACI-GA2LEN consensus 203
Molecular phenotyping and biomarker development: Are we on our way towards targeted therapy for severe asthma? 202
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 202
Anti-IL-5 and IL-5Ra: Efficacy and safety of new therapeutic strategies in severe uncontrolled asthma 199
Anti-Interleukin 5 (IL-5) and IL-5Ra Biological Drugs: Efficacy, Safety, and Future Perspectives in Severe Eosinophilic Asthma 199
NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation. 197
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 196
Mepolizumab in the management of severe eosinophilic asthma in adults: Current evidence and practical experience 193
Local Side Effects of Sublingual and Oral Immunotherapy 191
Absorption and distribution kinetics of the major Parietaria judaica allergen (Par j 1) administered by noninjectable routes in healthy human beings. 189
Analysis of the drop-out rate in patients receiving mepolizumab for severe asthma in real life 189
A survey of clinical features of allergic rhinitis in adults. 187
ARIA-ITALY multidisciplinary consensus on nasal polyposis and biological treatments 187
A WAO-ARIA-GA2LEN consensus document on molecular-based allergy diagnostics 186
Functionally relevant decreases in activatory receptor expression on NK cells are associated with pulmonary tuberculosis in vivo and persist after successful treatment. 183
A new protocol for specific oral tolerance induction in children with IgE-mediated cow's milk allergy. 183
Sublingual immunotherapy abrogates seasonal bronchial hyperresponsiveness in children with Parietaria-induced respiratory allergy: a randomized controlled trial. 181
A WAO — ARIA — GA2LEN consensus document on molecular-based allergy diagnosis (PAMD@): Update 2020 180
Basi Patogenetiche ed anatomopatologiche della flogosi allergica nell’asma bronchiale 177
Current insights in allergen immunotherapy 177
Venom immunotherapy in patients with clonal mast cell disorders: efficacy, safety, and practical considerations. 176
A critical appraisal on AIT in childhood asthma 176
Efficacy of Buffered Hypertonic Saline Nasal Irrigation for Nasal Symptoms in Children with Seasonal Allergic Rhinitis: A Randomized Controlled Trial 176
30 Years Of Sublingual Immunotherapy 176
Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials. 174
Bone mineral density, bone turnover markers and fractures in patients with indolent systemic mastocytosis. 174
Catching allergy by a simple questionnaire 174
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 174
Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation. 173
Nasal cytology: Methodology with application to clinical practice and research 173
Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma 172
Fibrous invasive (Riedel's) thyroiditis with critical response to steroid treatment. 171
When to stop biologicals. Severe asthma exacerbation after mepolizumab discontinuation 170
Targeting Interleukin-5 or Interleukin-5Rα: Safety Considerations 169
Manifesto on small airway involvement and management in asthma and chronic obstructive pulmonary disease: an Interasma (Global Asthma Association - GAA) and World Allergy Organization (WAO) document endorsed by Allergic Rhinitis and its Impact on Asthma (ARIA) and Global Allergy and Asthma European Network (GA2LEN) 169
Umeclidinium for the treatment of uncontrolled asthma 169
100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco. 169
Aerobiologic diagnosis of brassicaceae-induced asthma. 167
Allergen-specific nasal challenge: response kinetics of clinical and inflammatory events to rechallenge. 166
The additional values of microarray allergen assay in the management of polysensitized patients with respiratory allergy. 166
Antihistamines in atopic dermatitis. 165
CD4(+)IL-13(+) cells in peripheral blood well correlates with the severity of atopic dermatitis in children. 165
Allergenius, an expert system for the interpretation of allergen microarray results 165
Focus on cat allergen (Fel d 1): immunological and aerodynamic characteristics, modality of airway sensitization and avoidance strategies. 165
Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. 164
The safety of monoclonal antibodies in asthma 164
Benefit of SLIT and SCIT for Allergic Rhinitis and Asthma 164
Allergy and the bone: unexpected relationships. 163
A prospective italian survey on the safety of subcutaneous immunotherapy for respiratory allergy. 163
Serum cytotoxic T lymphocyte-associated antigen 4 in hymenoptera venom allergy and its modulation by specific immunotherapy 163
Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. 162
MK-8237: a house dust mite vaccine for treating allergic rhinitis, asthma and atopic dermatitis 162
2019 ARIA Care pathways for allergen immunotherapy 161
Latex-jujube cross-reactivity: case report and immunological study. 160
[Anti-leukotriene agents: rationale for and prospects of use]. 160
Efficacy of mepolizumab in patients with previous omalizumab treatment failure: Real-life observation 160
Appropriateness in allergic respiratory diseases health care in Italy: Definitions and organizational aspects 159
Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study 159
Allergic Rhinitis and its Impact on Asthma (ARIA): achievements in 10 years and future needs. 159
The natural history of respiratory allergy: a follow-up study of 99 patients up to 10 years 158
Continuous versus on demand treatment with cetirizine for allergic rhinitis. 158
Molecular diagnosis and precision medicine in allergy management 158
The path to personalized medicine in asthma 158
The role of basophil activation test in special populations with mastocytosis and reactions to hymenoptera sting. 157
Sublingual immunotherapy: World Allergy Organization position paper 2013 update 157
Sublingual immunotherapy. 155
When allergic rhinitis is not only allergic. 155
Continuous antihistamine treatment controls allergic inflammation and reduces respiratory morbidity in children with mite allergy. 154
The functional connection between oral allergy syndrome and united airways disease assessed by oral challenge. 154
Hymenoptera venom allergy in outdoor workers: Occupational exposure, clinical features and effects of allergen immunotherapy 154
Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum ctla-4 and IL-10. 154
Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. 154
MACVIA-ARIA Sentinel NetworK for allergic rhinitis (MASK-rhinitis): The new generation guideline implementation 153
Long-term follow-up of nasal immunotherapy to Parietaria: clinical and local immunological effects. 152
Antihistamines in the treatment of bronchial asthma. Present knowledge and future perspectives 152
An update on the asthma-rhinitis link. 152
New perspectives in the treatment of allergic rhinitis and asthma in children 152
How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers' viewpoint. 152
Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. 152
Executive summary of European Task Force document on diagnostic tools in rhinology. 152
[Immunotherapy in Latin America. From the past to the future]. 152
The classification of allergic rhinitis and its cytological correlate. 152
Sublingual and oral immunotherapy. 151
Is alternative medicine acceptable in allergology? 151
Prevalence of allergy to Cypress. 151
Cetirizine treatment of rhinitis in children with pollen allergy: evidence of its antiallergic activity. 151
Effect of adjuvanted and standard sublingual immunotherapy on respiratory function in pure rhinitis due to house dust mite over a 5-year period 151
AIRWAYS-ICPs (European Innovation Partnership on Active and Healthy Ageing) from concept to implementation 151
Totale 17.674
Salva come PNG Salva come JPEG
Categoria #
all - tutte 233.999
article - articoli 232.751
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.248
Totale 467.998
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20226.057 0 0 560 940 117 560 551 1.378 276 571 310 794
2022/20235.473 598 221 30 477 836 1.112 52 508 1.078 96 388 77
2023/20242.361 177 419 52 195 233 362 122 106 129 47 162 357
2024/20256.939 101 700 275 440 1.060 682 659 861 267 382 575 937
2025/202613.275 1.237 385 854 945 1.457 1.761 2.435 594 954 1.197 703 753
2026/20272.951 1.713 619 619 0 0 0 0 0 0 0 0 0
Totale 72.703